** Resonance Health RHT.AX falls 4.9% to A$0.039, its lowest level since August 12
** MedTech co reports annual loss attributable of A$1.7 million ($1.1 million) vs profit of A$169,303 last year
** However, co posts 29% y/y rise in annual revenue to A$11.1 mln
** About 686,104 shares traded, 1.5x the 30-day average
** YTD, stock down 25%, including current session's move
($1 = 1.5389 Australian dollars)
(Reporting by Ananya Verma in Bengaluru)
((ananya.verma@thomsonreuters.com;))